search for: pharma

Hi all there Can some one who have experience and knowledge in the pharma industry give me broad details on the subject "Statistical applications for pharma industry". I am new to the subject i.e. what kind of statistical tools used being unique /or atleast specific for pharma industry. It will be of great help as i am actively looking into the subject. thou...

------=_NextPart_84815C5ABAF209EF376268C8 Content-type: text/plain; charset=ISO-8859-1 Hello! This is just a quick note to inform you about an 80-page report on the Pharmaceutical Industry that we're able to provide you - at no cost. Compiled by some of the best analysts in the industry, the report provides an insight into the latest trends and strategies in the Pharmaceutical Industry. Over 50 pharma and biotech companies have been interviewed and benchmarked,...

Following up to some extent on Friday's discussion regarding the 'validation' of R, could I ask the list group's opinion on possible advantages of R over Splus from a pharma/devices perspective? I wish to exclude the obvious price difference, which doesn’t seem to carry as much weight as I would have thought. Besides, I have noticed many former Splus users gravitating towards R, and I suspect that the reasons are not purely economic. I can think of a few advantages...

Is there a function in R, which would return index of maximum value in a vector ? e.g. > v <- round(10*rnorm(8)) > v [1] 6 -3 -6 15 7 9 0 -19 > max(v) [1] 15 ??? index.max(v) ??? 4

Hello, I have a strange problem. I've re-included a XP SP3 pro in my samba domain. Only the administrators can authenticate and enter in a windows session. All other users can't. smb version : 3.3.5 Any help would be appreciate ... regards -- Herv? H?noch Responsable informatique Institut Sainte Catherine 1750, chemin du Lavarin, 84000 Avignon T?l?phone : 04.90.27.57.44

Hi All, We're interested in finding other users of R in pharmaceutical companies. Please reply if you are or know of someone who is. -Greg Gregory R. Warnes, Ph.D. Pfizer Global Research and Development LEGAL NOTICE Unless expressly stated otherwise, this message is confidential and may be privileged. It is intended for the addressee(s) only. Access to t...

...her asks for a password or not. When it asks for the password, I get the cannot find the domain error on the client and the PAM ERROR 12 on the syslog. Regards Enrico ----- Original Message ----- From: "Andrew Bartlett" <abartlet@samba.org> To: "Enrico Payne" <enricop@pharma.co.za> Cc: <samba@lists.samba.org>; "John H Terpstra" <jht@samba.org>; "Andreas" <andreas@conectiva.com.br>; "Andrew Bartlett" <abartlet@samba.org> Sent: Thursday, August 28, 2003 4:29 PM Subject: Re: [Samba] Forcing password changes using SA...

________________________________ Principal Post-Doctoral Fellow PKPD modelling platform (full time) Leiden University, Leiden, The Netherlands <javascript:doredirect();> Job description ________________________________ TOP Institute Pharma (TI Pharma) has granted our proposal to set up a mechanism-based PK-PD modelling platform. This platform focuses on the transfer of knowledge from academia to the pharmaceutical industry and is a collaborative effort of four excellent academic institutes and six leading global pharmaceutical indust...

...ssage. Best wishes, Margot Beukers Unique PK-PD modeling platform established in The Netherlands Are you our ambitious IT platform manager with a profound drive to contribute to a new era of drug research? PK-PD modeling platform Prof. dr. Meindert Danhof heads the "TI Pharma mechanism-based PK-PD modeling platform". Our unique platform will house a shared database for the purpose of mechanism-based PK-PD model building. As underscored in the Critical Path to New Medicines report by the FDA, our models are essential to revert the current attrition rate of new drugs...

Post-Doctoral Fellowship Modelling of Cardiovascular Safety (full time) Leiden University, Leiden, The Netherlands <javascript:doredirect();> Job description TOP Institute Pharma (TI Pharma) has granted our proposal to set up a mechanism-based PKPD modelling platform. This platform focuses on the transfer of knowledge from academia to the pharmaceutical industry and is a collaborative effort of four excellent academic institutes and six leading global pharmaceutical industr...

...I have visited the revolution computing web page, but its not clear when or what will be the new release be. Does anybody have information about that?. Does anybody know if the version that will be released will be validated?. I have been reading the previous mails about validation and I work in a Pharma company and validation is a big concern. Thank you Mariana _________________________________________________________________ Descargá GRATIS el poder del nuevo Internet Explorer 7. [[alternative HTML version deleted]]

I have a data frame (df) with colums x, y and z. e.g. df <- data.frame(x = sample(4), y = sample(4), z = sample(4)) I can extract column z by: df$z or df[3] I can also extract columns x,y by: df[1:2] or by df[-3]. Is it possible to extract x,y columns in a "symbolic" fashion i.e. by equivalent of df[-z] (which is illegal) ??? Or alternativeley, is there an equivalent of

...f this result. Is it because the effect of Z within families is not very strong, but between family variation is high? ----------------------------------------------------------------- If my R syntax would be helpful, it's below: BIG EFFECT OF Z (using lm) summary(lm(Y ~ X + Z + age ,data=pharma.data ,na.action='na.omit')) Estimate Std. Error t value Pr(>|t|) (Intercept) 102.27 24.98 4.09 7e-05 *** X -629.76 267.87 -2.35 0.020 * Z -4511.96 2032.39 -2.22 0.028 * age 1.88 1.42 1.32 0.188 SMALLER EFFECT OF...

TOP Institute Pharma (TI Pharma) has granted our proposal to set up a mechanism-based PKPD modelling platform. This platform focuses on the transfer of knowledge from academia to the pharmaceutical industry and is a collaborative effort of four excellent academic institutes and six leading global pharmaceutical ind...

In e1071 package/svm default epsilon value is set to 0.1 and not 0.5 as documentation says. R

Two Postdoctoral fellows (fulltime) Leiden University, Leiden, The Netherlands Job description ________________________________________ TOP Institute Pharma (TI Pharma) has granted our proposal to set up a mechanism-based PK-PD modelling platform. This platform focuses on the transfer of knowledge from academia to the pharmaceutical industry and is a collaborative effort of four academic partners and six industrial partners. Unique to this platform is...

I don't know the details of pls (in the pls.pcr package, I assume), but if you use validation="CV", that says you want to use CV to select the best number of components. Then why would you specify ncomp as well? Andy > From: ryszard.czerminski at pharma.novartis.com > > When I try to use ncomp parameter in pls procedure I get > following error: > > > library(pls.pcr) > > m <- pls(x, y, validation = "CV", niter = 68, ncomp = 16) > Error in inherits(x, "data.frame") : subscript out of bounds >...

How can I select random subsets (rows!) from a data set ? If I generate simple data set > a <- data.frame(x=1:2, y = NaN, z = 2:1) > a x y z 1 1 NaN 2 2 2 NaN 1 I can select random subsets (colums) very easily using sample function: > sample(a, 2) z y 1 2 NaN 2 1 NaN I expected that using transpose of a would do the same for rows, but I am getting rather unexpected

...o announce the new R meeting to be held in Basel, Switzerland. BaselR will be held from 6:30-9:30pm on Tues, Apr 27 at TransBARent: http://transbarent.business.sv-group.ch Doors open at 6:30,pm with the presentations starting at 7:00pm Introduction: What is Basel R? Andreas Krause:... Graphing Pharma Data Yann Abraham: Graphics Charles Roosen: Web based R reporting (This agenda is yet to be finalised. We will notify any changes) For further information or to register, please contact: baselr@mango-solutions.com Please also visit - www.mango-solutions.com and www.londonr.org Sarah Lew...

...and have a concern about my Samba servers. I am getting a number of messages on the consoles of both my Samba servers, it reads "smb-retry: signal failed, error=-3" Can someone please explain this to me? Also, is there a list of error codes for Samba? Regards Enrico Payne IT Manager - Pharma Natura http://www.pharma.co.za mailto:enricop@pharma.co.za